May 21st 2024
A recent study reveals no significant association between COVID-19 vaccination and the incidence of abnormal uterine bleeding among reproductive-aged women.
23rd Annual International Congress on the Future of Breast Cancer® East
July 19-20, 2024
Register Now!
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 2025
View More
Addressing racial and ethnic disparities in brachial plexus birth Injury
May 20th 2024Mary Claire B. Manske, MD, discusses her findings on the unexplained increased risk of brachial plexus birth injury among Black and Hispanic infants, highlighting the need for improved prenatal care and further research.
Empowering ob-gyns to address sexual health concerns
May 18th 2024At the 2024 ACOG Annual Clinical & Scientific Meeting, experts emphasized the importance of equipping ob-gyns with the knowledge and tools to address sexual health issues, including hyperactive sexual desire disorder, anorgasmia, and pelvic pain.
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Mastering misoprostol: Comprehensive uses across trimesters
May 17th 2024Leanne R. McCloskey, MD, and Weronika A. Armstrong, MD, xplore the multifaceted applications of misoprostol in obstetrics, covering protocols, safety, and the impact on birth equity from early pregnancy loss to labor induction at ACOG 2024.
Navigating vasomotor symptoms in breast cancer patients
May 17th 2024Michelle Jacobson, MD, MHSc, FRCSC, shares critical perspectives on managing vasomotor symptoms in breast cancer patients at the recent ACOG Annual Clinical & Scientific Meeting, emphasizing the importance of tailored approaches amidst evolving treatment options and patient risks.
Study reveals critical gaps in care for PCOS patients
May 17th 2024A new study presented at the 2024 ACOG Annual Clinical and Scientific Meeting highlighted significant gaps in polycystic ovary syndrome (PCOS) care, revealing widespread patient dissatisfaction and the urgent need for improved provider education and comprehensive treatment approaches.
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Impact of antiepileptic medications and sex hormones on maternal and child outcomes in epilepsy
May 16th 2024Paula Emanuela Voinescu, MD, PhD, director of the Women's Epilepsy Program at Brigham and Women's Hospital, talked about the influence of sex hormones on maternal outcomes in pregnant women with epilepsy treated with antiseizure medication.
PCOS and irregular cycles tied to cardiometabolic risks
May 15th 2024A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.